March 9 (Tue) Room A

Special Lecture5
2-SL59:0010:00
Human organoid for pharmaceutical science
Takanori Takebe
Institute of Research, Tokyo Medical and Dental University
Special Lecture6
2-SL610:0011:00
Harnessing gut commensals to combat disease
Kenya Honda
Dep. Microbiol. and Immunol., Keio Univ, Med.
Education Lecture
2-EL11:0012:00
Drug Discovery of Gilteritinib, novel FLT3 inhibitor, for Acute Myeloid Leukemia
Sadao Kuromitsu
Candidate Discovery Science Labs, Drug Discovery Research, Astellas Pharma Inc.
Plenary Lecture
2-PL13:0014:00
Orexin / hypocretin receptor antagonists and agonists in neuropsychiatric disorders
Daniel Hoyer
Department of Pharmacology and Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne
JPS-ASCEPT Lecture
2-JAL15:3016:30
The structural basis of class B GPCR activation and signalling
Denise Wootten
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences
Special Lecture7
2-SL716:3017:30
Lessons learned from elucidating calcium-dependent neural circuit control mechanisms
Haruhiko Bito
Dept. Neurochem., The Univ of Tokyo Grad Sch Med
The 14th Ebashi Setsuro Award Lecture
2-SL817:4518:45
Translational research targeting inflammatory responses and development of novel drugs
Masahiro Nishibori
Dept. Pharmacol., Okayama Univ. Grad. Sch. Med. Dent & Pharmaceut Sci.
pagetop